cc3926 CCJ Correction <p>Correction: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings</p> Grounds R Michael m.grounds@blueyonder.co.uk Bolan Charles

Adult Intensive Care Unit, St George's Hospital, London, UK

COL (retired) US Army Medical Corps, Deputy Chief, Blood Services Section, Department of Transfusion Medicine, Clinical Centre, National Institutes of Health, Bethesda, Maryland, USA

 Critical Care 1364-8535 2005 9 6 560 10.1186/cc3926 4 11 2005 2005 BioMed Central Ltd

Following the publication of the above article 1, we noticed that the Competing interests section was incorrect and should read as follows:

RMG has worked as a consultant for Novo Nordisk and lectured on behalf of Novo Nordisk about NovoSeven.

 <p>Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings</p> Grounds RM Bolan C Crit Care 2005 9 Suppl 5 S29 S36 10.1186/cc3783 16221317